Microbial Tyrosol Production via Metabolic Pathway Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production of tyrosol and its glucoside, salidroside, is hindered by low natural concentrations in plants, leading to high commercial production costs and complex extraction processes, and current chemical synthesis methods are inefficient.
Innovation Solution
A method involving transgenic bacterial cells that heterologously express specific enzymes such as phenylpyruvate decarboxylase, phospho-2-dehydro-3-deoxyheptonate aldolase, and prephenate dehydrogenase, with additional expression of uridine diphosphate dependent glycosyltransferase for salidroside production, grown in a medium with phosphoenolpyruvate and erythrose 4-phosphate, and optionally phenylalanine, to enhance tyrosol and salidroside yields.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If tyrosol is extracted from plants, then tyrosol can be obtained, but the yield is low and production costs are high
Solution Approach 1:
The patent creates a bacterial copy of the plant's tyrosol biosynthetic pathway by introducing heterologous genes (ARO10 for phenylpyruvate decarboxylase, aroF for phospho-2-dehydro-3-deoxyheptonate aldolase, and tyrA for prephenate dehydrogenase) into E. coli. This microbial factory reproduces the natural plant metabolism, achieving high-yield tyrosol production without relying on plant extraction.
2Productivity
If chemical synthesis methods are used for tyrosol production, then production can be scaled, but efficiency and commercial viability are insufficient
Solution Approach 1:
The transgenic bacterial system performs self-service by using its own metabolic machinery to convert readily available substrates (glucose, phenylalanine) into tyrosol. The bacteria's endogenous pathways are redirected through genetic engineering to autonomously produce tyrosol, eliminating the need for complex chemical synthesis steps and improving both efficiency and commercial viability.
3Quantity of substance
If the phenylpyruvate decarboxylase pathway is introduced, then tyrosol production is enabled, but competing pathways consume precursors and reduce yield
Solution Approach 1:
The patent extracts or removes the competing phenylacetaldehyde dehydrogenase activity by inactivating the feaB gene, which normally consumes phenylacetaldehyde in a competing pathway. This eliminates the metabolic drain on precursors and redirects all flux toward tyrosol production, significantly increasing yield.
Solution Approach 2:
The patent applies local quality control by specifically modifying the metabolic pathway at critical nodes: overexpressing aroF and tyrA to enhance precursor supply to phenylpyruvate, and inactivating feaB to prevent competitor pathway activity. This targeted optimization ensures maximum precursor allocation to tyrosol production.
4Quantity of substance
If natural plant sources are used, then tyrosol can be obtained, but extraction processes are complex and yields are low
Solution Approach 1:
The patent replaces the mechanical/physical extraction process from plants with a biochemical production system in bacteria. Instead of using complex extraction apparatus and multiple purification steps, the transgenic bacteria directly secrete or accumulate tyrosol in the culture medium, which can be obtained through simple fermentation and extraction, dramatically simplifying the process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the yield and efficiency of tyrosol and salidroside production, reducing costs and simplifying the extraction process by leveraging genetically engineered bacteria to optimize metabolic pathways.
Implementation Method 1
a transgenic bacterial cell that heterologously expresses phenylpyruvate decarboxylase
Implementation Method 2
overexpresses phospho-2-dehydro-3-deoxyheptonate aldolase
Implementation Method 3
overexpresses prephenate dehydrogenase
Implementation Method 4
heterologously expresses uridine diphosphate dependent glycosyltransferase (UGT85A1, EC:2.4.1.)
Data Source
AI summary
The invention relates to a method for production of tyrosol, wherein a transgenic bacterial cell that heterologously expresses phenylpyruvate decarboxylase and that overexpresses phospho-2-dehydro-3-deoxyheptonate and prephenate dehydrogenase, and wherein pheAL and feaB are both inactivated or removed, is grown in a medium comprising a metabolic precursor of phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P), particularly glucose, and optionally, phenylalanine as a supplement; and tyrosol is extracted from said medium. The invention also relates to a method for production of salidroside, wherein the transgenic cell additionally heterologously expresses uridine diphosphate dependent glycosyltransferase (UGT85A1, EC:2.4.1.)